TY  - JOUR
AU  - Marrugal-Lorenzo, José A
AU  - Serna-Gallego, Ana
AU  - Berastegui-Cabrera, Judith
AU  - Pachón, Jerónimo
AU  - Sánchez-Céspedes, Javier
PY  - 2019
DO  - 10.1038/s41598-018-37290-3
UR  - http://hdl.handle.net/10668/13403
T2  - Scientific reports
AB  - The repositioning of drugs already approved by regulatory agencies for other indications is an emerging alternative for the development of new antimicrobial therapies. The repositioning process involves lower risks and costs than the de novo...
LA  - en
KW  - A549 Cells
KW  - Adenoviridae
KW  - Adenoviridae Infections
KW  - Antiviral Agents
KW  - Community-Acquired Infections
KW  - Drug Repositioning
KW  - HEK293 Cells
KW  - Humans
KW  - Niclosamide
KW  - Oxyclozanide
KW  - Rafoxanide
TI  - Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections.
TY  - research article
VL  - 9
ER  -